335 related articles for article (PubMed ID: 32660036)
1. Desmoid-Type Fibromatosis.
Garcia-Ortega DY; Martín-Tellez KS; Cuellar-Hubbe M; Martínez-Said H; Álvarez-Cano A; Brener-Chaoul M; Alegría-Baños JA; Martínez-Tlahuel JL
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32660036
[TBL] [Abstract][Full Text] [Related]
2. Multifocal occurrence of extra-abdominal desmoid type fibromatosis - A rare manifestation. A clinicopathological study of 6 sporadic cases and 1 hereditary case.
Bekers EM; van Broekhoven DLM; van Dalen T; Bonenkamp JJ; van der Geest ICM; de Rooy JWJ; van Gorp JM; Creytens DH; de Leng WWJ; Scheijen B; Eijkelenboom A; Flucke U
Ann Diagn Pathol; 2018 Aug; 35():38-41. PubMed ID: 29705714
[TBL] [Abstract][Full Text] [Related]
3. Molecular Pathogenesis of Sporadic Desmoid Tumours and Its Implications for Novel Therapies: A Systematised Narrative Review.
McLean TD; Duchi S; Di Bella C
Target Oncol; 2022 May; 17(3):223-252. PubMed ID: 35446005
[TBL] [Abstract][Full Text] [Related]
4. Radiation-induced Sarcomas Occurring in Desmoid-type Fibromatosis Are Not Always Derived From the Primary Tumor.
Verschoor AJ; Cleton-Jansen AM; Wijers-Koster P; Coffin CM; Lazar AJ; Nout RA; Rubin BP; Gelderblom H; Bovée JV
Am J Surg Pathol; 2015 Dec; 39(12):1701-7. PubMed ID: 26414222
[TBL] [Abstract][Full Text] [Related]
5. Detection of beta-catenin mutations in paraffin-embedded sporadic desmoid-type fibromatosis by mutation-specific restriction enzyme digestion (MSRED): an ancillary diagnostic tool.
Amary MF; Pauwels P; Meulemans E; Roemen GM; Islam L; Idowu B; Bousdras K; Diss TC; O'Donnell P; Flanagan AM
Am J Surg Pathol; 2007 Sep; 31(9):1299-309. PubMed ID: 17721184
[TBL] [Abstract][Full Text] [Related]
6. Is mutation analysis of β-catenin useful for the diagnosis of desmoid-type fibromatosis? A systematic review.
Sakai T; Hamada S; Koike H; Shimizu K; Yoshida M; Nishida Y
Jpn J Clin Oncol; 2020 Sep; 50(9):1037-1042. PubMed ID: 32533146
[TBL] [Abstract][Full Text] [Related]
7. Complex Case of Aggressive Intra-abdominal Desmoid-type Fibromatosis Status Post Cholecystectomy.
Rangunwala J; Sitta J; Prakash V; Vyas K; Roda M
Cureus; 2020 Mar; 12(3):e7193. PubMed ID: 32269873
[TBL] [Abstract][Full Text] [Related]
8. Identification of Familial Adenomatous Polyposis carriers among children with desmoid tumours.
Kattentidt Mouravieva AA; Geurts-Giele IR; de Krijger RR; van Noesel MM; van de Ven CP; van den Ouweland AM; Kromosoeto JN; Dinjens WN; Dubbink HJ; Smits R; Wagner A
Eur J Cancer; 2012 Aug; 48(12):1867-74. PubMed ID: 22305464
[TBL] [Abstract][Full Text] [Related]
9. Desmoid tumors: diagnostic and therapeutic considerations.
Brener-Chaoul M; Cervantes-Gutiérrez Ó; Padilla-Longoria R; Martín-Téllez KS
Gac Med Mex; 2020; 156(5):439-445. PubMed ID: 33372933
[TBL] [Abstract][Full Text] [Related]
10. Increased beta-catenin protein and somatic APC mutations in sporadic aggressive fibromatoses (desmoid tumors).
Alman BA; Li C; Pajerski ME; Diaz-Cano S; Wolfe HJ
Am J Pathol; 1997 Aug; 151(2):329-34. PubMed ID: 9250146
[TBL] [Abstract][Full Text] [Related]
11. [Mesogastric desmoid tumor, a rare entity].
Lapaille L; Mutijima E; Loly C
Rev Med Liege; 2020 Jul; 75(7-8):548-552. PubMed ID: 32779910
[TBL] [Abstract][Full Text] [Related]
12. Comparison of sporadic and FAP-associated desmoid-type fibromatoses.
Koskenvuo L; Ristimäki A; Lepistö A
J Surg Oncol; 2017 Nov; 116(6):716-721. PubMed ID: 28570749
[TBL] [Abstract][Full Text] [Related]
13. β-catenin (CTNNB1) mutations and clinicopathological features of mesenteric desmoid-type fibromatosis.
Huss S; Nehles J; Binot E; Wardelmann E; Mittler J; Kleine MA; Künstlinger H; Hartmann W; Hohenberger P; Merkelbach-Bruse S; Buettner R; Schildhaus HU
Histopathology; 2013 Jan; 62(2):294-304. PubMed ID: 23020601
[TBL] [Abstract][Full Text] [Related]
14. Aggressive fibromatosis (desmoid tumors): definition, occurrence, pathology, diagnostic problems, clinical behavior, genetic background.
Ferenc T; Sygut J; Kopczyński J; Mayer M; Latos-Bieleńska A; Dziki A; Kulig A
Pol J Pathol; 2006; 57(1):5-15. PubMed ID: 16739877
[TBL] [Abstract][Full Text] [Related]
15. A germline mutation at the extreme 3' end of the APC gene results in a severe desmoid phenotype and is associated with overexpression of beta-catenin in the desmoid tumor.
Couture J; Mitri A; Lagace R; Smits R; Berk T; Bouchard HL; Fodde R; Alman B; Bapat B
Clin Genet; 2000 Mar; 57(3):205-12. PubMed ID: 10782927
[TBL] [Abstract][Full Text] [Related]
16. Clinical Activity of the γ-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors (Aggressive Fibromatosis).
Kummar S; O'Sullivan Coyne G; Do KT; Turkbey B; Meltzer PS; Polley E; Choyke PL; Meehan R; Vilimas R; Horneffer Y; Juwara L; Lih A; Choudhary A; Mitchell SA; Helman LJ; Doroshow JH; Chen AP
J Clin Oncol; 2017 May; 35(14):1561-1569. PubMed ID: 28350521
[TBL] [Abstract][Full Text] [Related]
17. CTNNB1 genotyping and APC screening in pediatric desmoid tumors: a proposed algorithm.
Wang WL; Nero C; Pappo A; Lev D; Lazar AJ; López-Terrada D
Pediatr Dev Pathol; 2012; 15(5):361-7. PubMed ID: 22372443
[TBL] [Abstract][Full Text] [Related]
18. Desmoid fibromatosis of the esophagogastric junction.
Díaz Ruiz R; Flores Fernández V; Pajares Díaz JA
Rev Esp Enferm Dig; 2018 Oct; 110(10):677-678. PubMed ID: 30168335
[TBL] [Abstract][Full Text] [Related]
19. An unusual finding in a desmoid-type fibromatosis of the pancreas: a case report and review of the literature.
Torres JC; Xin C
J Med Case Rep; 2018 May; 12(1):123. PubMed ID: 29751773
[TBL] [Abstract][Full Text] [Related]
20. Tailored Beta-catenin mutational approach in extra-abdominal sporadic desmoid tumor patients without therapeutic intervention.
van Broekhoven DL; Grünhagenl DJ; van Dalen T; van Coevorden F; Bonenkamp HJ; Been LB; Bemelmans MH; Dijkstra SD; Colombo C; Gronchi A; Verhoef C
BMC Cancer; 2016 Aug; 16(1):686. PubMed ID: 27565718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
